Alterity Therapeutics LTD (ATHE) — SEC Filings

Latest SEC filings for Alterity Therapeutics LTD. Recent 6-K filing on Apr 17, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Alterity Therapeutics LTD on SEC EDGAR

Overview

Alterity Therapeutics LTD (ATHE) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Apr 16, 2026: Alterity Therapeutics Ltd. filed a Form 6-K on April 16, 2026, reporting for the period ending April 30, 2026. The filing includes the form itself, an exhibit (EX-99.1), and a graphic image. The company is based in Melbourne, Australia, and operates in the Pharmaceutical Preparations sector.

Sentiment Summary

Across 5 filings, the sentiment breakdown is: 5 neutral. The dominant filing sentiment for Alterity Therapeutics LTD is neutral.

Filing Type Overview

Alterity Therapeutics LTD (ATHE) has filed 5 6-K with the SEC between Mar 2026 to Apr 2026.

Recent Filings (5)

Frequently Asked Questions

What are the latest SEC filings for Alterity Therapeutics LTD (ATHE)?

Alterity Therapeutics LTD has 5 recent SEC filings from Mar 2026 to Apr 2026, including 5 6-K. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of ATHE filings?

Across 5 filings, the sentiment breakdown is: 5 neutral. The dominant sentiment is neutral.

Where can I find Alterity Therapeutics LTD SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Alterity Therapeutics LTD (ATHE) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

View on Read The Filing